ADD	After-discharge duration
ADT	After-discharge threshold
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ASM	Antiseizure medication
BBB	Blood–brain barrier
COX	Cyclooxygenase
CYP	Cytochrome P450
DRE	Drug-resistant epilepsy
ED50	Median effective dose
ETX	Ethosuximide
GABA	γ-Aminobutyric acid
GABA-AT	GABA aminotransferase
GAERS	Genetic absence epilepsy rat from Strasbourg
GTC	Generalized tonic–clonic
i.p.	Intraperitoneal
i.v.	Intravenous
LCS	Lacosamide
LEV	Levetiracetam
LTG	Lamotrigine
MES	Maximal electroshock seizure
nAChR	Nicotinic acetylcholine receptor
NMDA	N-methyl-D-aspartate
PAM	Positive allosteric modulator
P-gp	P-glycoprotein
PHT	Phenytoin
PTZ	pentylenetetrazole
SA	Sebacic acid
s.c.	Subcutaneous
SE	Status epilepticus
SRS	Spontaneous recurrent seizure
TD50	Median toxic dose
TLE	Temporal lobe epilepsy
VGSC	Voltage-gated sodium channel
VPA	Valproic acid